| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial
|
Arora, Ashwani K.
|
|
|
40 |
41 |
p. 5924-5932
|
artikel
|
| 2 |
COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members
|
Ulrich, Angela K.
|
|
|
40 |
41 |
p. 5856-5859
|
artikel
|
| 3 |
Development and characterization of a novel conjugated methamphetamine vaccine
|
Kamal Hossain, Md
|
|
|
40 |
41 |
p. 5882-5891
|
artikel
|
| 4 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
41 |
p. IFC
|
artikel
|
| 5 |
Educational videos to address vaccine hesitancy in childhood immunization
|
Lubis, Teti Adriana
|
|
|
40 |
41 |
p. 5965-5970
|
artikel
|
| 6 |
Epidemiology and pre-vaccine burden of rotavirus diarrhea in Democratic Republic of Congo (DRC): Results of sentinel surveillance, 2009–2019
|
Luhata Lungayo, Christophe
|
|
|
40 |
41 |
p. 5933-5941
|
artikel
|
| 7 |
Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis
|
Palmer, Matthew
|
|
|
40 |
41 |
p. 5971-5996
|
artikel
|
| 8 |
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus
|
Mok, Chi Chiu
|
|
|
40 |
41 |
p. 5959-5964
|
artikel
|
| 9 |
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
|
Hemmi, Takuya
|
|
|
40 |
41 |
p. 5892-5903
|
artikel
|
| 10 |
Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland
|
Nuorti, J. Pekka
|
|
|
40 |
41 |
p. 5950-5958
|
artikel
|
| 11 |
Modern biotechnological strategies for vaccine development in aquaculture – Prospects and challenges
|
Jose Priya, T.A.
|
|
|
40 |
41 |
p. 5873-5881
|
artikel
|
| 12 |
Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia
|
Qi, Li
|
|
|
40 |
41 |
p. 5912-5923
|
artikel
|
| 13 |
Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
|
Williams, Erin
|
|
|
40 |
41 |
p. 5868-5872
|
artikel
|
| 14 |
Role of TLR2/MyD88 in the production of specific IgM and IgG antibodies during the immunization of mice against Neospora caninum
|
Ferreira Silva, Mariana
|
|
|
40 |
41 |
p. 5860-5867
|
artikel
|
| 15 |
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain
|
Sánchez-Saez, Francisco
|
|
|
40 |
41 |
p. 5942-5949
|
artikel
|
| 16 |
Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink
|
Lewin, Bruno
|
|
|
40 |
41 |
p. 5904-5911
|
artikel
|
| 17 |
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022
|
Prudden, Holly J.
|
|
|
40 |
41 |
p. 5843-5855
|
artikel
|
| 18 |
Vasovagal reactions after COVID-19 vaccination in Japan
|
Okuyama, Mai
|
|
|
40 |
41 |
p. 5997-6000
|
artikel
|
Tijdschrift beschrijving